UTX Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of UTX Antibodies for advanced research in the field of epigenetics. UTX Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UTX, or Ubiquitously Transcribed Tetratricopeptide Repeat, is a histone demethylase that plays a key role in the regulation of gene expression by modifying histone methylation marks. Its function is essential for processes such as cell differentiation, development, and response to environmental signals. Dysregulation of UTX has been implicated in various diseases, including cancer, making it a significant target for research. UTX monoclonal antibodies enable detailed investigation of chromatin modifications and their impact on cellular processes. Researchers can effectively track UTX localization and activity within cells, advancing understanding of epigenetic regulation mechanisms. UTX research with monoclonal antibodies has revealed important insights into developmental biology and disease progression. Santa Cruz Biotechnology monoclonal antibodies for UTX support researchers worldwide in advancing scientific knowledge and developing potential therapeutic approaches.